Global Recombinant Trypsin Solution Market Research Report 2025

Publication ID:

PB501256126

Publication Date:

January 14, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Recombinant Trypsin Solution was valued at US$ 26.6 million in the year 2024 and is projected to reach a revised size of US$ 44.1 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
Global Recombinant Trypsin Solution key players include Novozymes, BBI Group, etc. Global top two manufacturers hold a share about 57%.
North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 45 percent.
In terms of product, Liquid is the largest segment, with a share about 65%. And in terms of application, the largest application is Cell Culture, followed by Insulin Manufacturing, Vaccines Manufacturing, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Trypsin Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Trypsin Solution.
The Recombinant Trypsin Solution market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Trypsin Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Trypsin Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novozymes
BBI Group
Roche
Thermo Fisher
Merck
Applied Biotechnology Institute
Biological Industries
Yaxin Bio
Yocon Hengye Bio
BasalMedia
Biosera
Segment by Type
Solid
Liquid
Segment by Application
Insulin Manufacturing
Vaccines Manufacturing
Cell Culture
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Trypsin Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Trypsin Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Recombinant Trypsin Solution Market Overview
1.1 Product Definition
1.2 Recombinant Trypsin Solution by Type
1.2.1 Global Recombinant Trypsin Solution Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solid
1.2.3 Liquid
1.3 Recombinant Trypsin Solution by Application
1.3.1 Global Recombinant Trypsin Solution Market Value by Application (2024 VS 2031)
1.3.2 Insulin Manufacturing
1.3.3 Vaccines Manufacturing
1.3.4 Cell Culture
1.3.5 Other
1.4 Global Recombinant Trypsin Solution Market Size Estimates and Forecasts
1.4.1 Global Recombinant Trypsin Solution Revenue 2020-2031
1.4.2 Global Recombinant Trypsin Solution Sales 2020-2031
1.4.3 Global Recombinant Trypsin Solution Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Trypsin Solution Market Competition by Manufacturers
2.1 Global Recombinant Trypsin Solution Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Trypsin Solution Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Trypsin Solution Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Trypsin Solution, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Trypsin Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Trypsin Solution, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Trypsin Solution, Date of Enter into This Industry
2.8 Global Recombinant Trypsin Solution Market Competitive Situation and Trends
2.8.1 Global Recombinant Trypsin Solution Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Trypsin Solution Players Market Share by Revenue
2.8.3 Global Recombinant Trypsin Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Trypsin Solution Market Scenario by Region
3.1 Global Recombinant Trypsin Solution Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Trypsin Solution Sales by Region: 2020-2031
3.2.1 Global Recombinant Trypsin Solution Sales by Region: 2020-2025
3.2.2 Global Recombinant Trypsin Solution Sales by Region: 2026-2031
3.3 Global Recombinant Trypsin Solution Revenue by Region: 2020-2031
3.3.1 Global Recombinant Trypsin Solution Revenue by Region: 2020-2025
3.3.2 Global Recombinant Trypsin Solution Revenue by Region: 2026-2031
3.4 North America Recombinant Trypsin Solution Market Facts & Figures by Country
3.4.1 North America Recombinant Trypsin Solution Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Trypsin Solution Sales by Country (2020-2031)
3.4.3 North America Recombinant Trypsin Solution Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Trypsin Solution Market Facts & Figures by Country
3.5.1 Europe Recombinant Trypsin Solution Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Trypsin Solution Sales by Country (2020-2031)
3.5.3 Europe Recombinant Trypsin Solution Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Trypsin Solution Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Trypsin Solution Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Trypsin Solution Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Trypsin Solution Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Trypsin Solution Market Facts & Figures by Country
3.7.1 Latin America Recombinant Trypsin Solution Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Trypsin Solution Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Trypsin Solution Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Trypsin Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Trypsin Solution Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Trypsin Solution Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Trypsin Solution Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Trypsin Solution Sales by Type (2020-2031)
4.1.1 Global Recombinant Trypsin Solution Sales by Type (2020-2025)
4.1.2 Global Recombinant Trypsin Solution Sales by Type (2026-2031)
4.1.3 Global Recombinant Trypsin Solution Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Trypsin Solution Revenue by Type (2020-2031)
4.2.1 Global Recombinant Trypsin Solution Revenue by Type (2020-2025)
4.2.2 Global Recombinant Trypsin Solution Revenue by Type (2026-2031)
4.2.3 Global Recombinant Trypsin Solution Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Trypsin Solution Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Trypsin Solution Sales by Application (2020-2031)
5.1.1 Global Recombinant Trypsin Solution Sales by Application (2020-2025)
5.1.2 Global Recombinant Trypsin Solution Sales by Application (2026-2031)
5.1.3 Global Recombinant Trypsin Solution Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Trypsin Solution Revenue by Application (2020-2031)
5.2.1 Global Recombinant Trypsin Solution Revenue by Application (2020-2025)
5.2.2 Global Recombinant Trypsin Solution Revenue by Application (2026-2031)
5.2.3 Global Recombinant Trypsin Solution Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Trypsin Solution Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novozymes
6.1.1 Novozymes Company Information
6.1.2 Novozymes Description and Business Overview
6.1.3 Novozymes Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novozymes Recombinant Trypsin Solution Product Portfolio
6.1.5 Novozymes Recent Developments/Updates
6.2 BBI Group
6.2.1 BBI Group Company Information
6.2.2 BBI Group Description and Business Overview
6.2.3 BBI Group Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BBI Group Recombinant Trypsin Solution Product Portfolio
6.2.5 BBI Group Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Recombinant Trypsin Solution Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Thermo Fisher
6.4.1 Thermo Fisher Company Information
6.4.2 Thermo Fisher Description and Business Overview
6.4.3 Thermo Fisher Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Recombinant Trypsin Solution Product Portfolio
6.4.5 Thermo Fisher Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Recombinant Trypsin Solution Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Applied Biotechnology Institute
6.6.1 Applied Biotechnology Institute Company Information
6.6.2 Applied Biotechnology Institute Description and Business Overview
6.6.3 Applied Biotechnology Institute Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Applied Biotechnology Institute Recombinant Trypsin Solution Product Portfolio
6.6.5 Applied Biotechnology Institute Recent Developments/Updates
6.7 Biological Industries
6.7.1 Biological Industries Company Information
6.7.2 Biological Industries Description and Business Overview
6.7.3 Biological Industries Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biological Industries Recombinant Trypsin Solution Product Portfolio
6.7.5 Biological Industries Recent Developments/Updates
6.8 Yaxin Bio
6.8.1 Yaxin Bio Company Information
6.8.2 Yaxin Bio Description and Business Overview
6.8.3 Yaxin Bio Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yaxin Bio Recombinant Trypsin Solution Product Portfolio
6.8.5 Yaxin Bio Recent Developments/Updates
6.9 Yocon Hengye Bio
6.9.1 Yocon Hengye Bio Company Information
6.9.2 Yocon Hengye Bio Description and Business Overview
6.9.3 Yocon Hengye Bio Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Yocon Hengye Bio Recombinant Trypsin Solution Product Portfolio
6.9.5 Yocon Hengye Bio Recent Developments/Updates
6.10 BasalMedia
6.10.1 BasalMedia Company Information
6.10.2 BasalMedia Description and Business Overview
6.10.3 BasalMedia Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BasalMedia Recombinant Trypsin Solution Product Portfolio
6.10.5 BasalMedia Recent Developments/Updates
6.11 Biosera
6.11.1 Biosera Company Information
6.11.2 Biosera Description and Business Overview
6.11.3 Biosera Recombinant Trypsin Solution Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biosera Recombinant Trypsin Solution Product Portfolio
6.11.5 Biosera Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Trypsin Solution Industry Chain Analysis
7.2 Recombinant Trypsin Solution Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Trypsin Solution Production Mode & Process Analysis
7.4 Recombinant Trypsin Solution Sales and Marketing
7.4.1 Recombinant Trypsin Solution Sales Channels
7.4.2 Recombinant Trypsin Solution Distributors
7.5 Recombinant Trypsin Solution Customer Analysis
8 Recombinant Trypsin Solution Market Dynamics
8.1 Recombinant Trypsin Solution Industry Trends
8.2 Recombinant Trypsin Solution Market Drivers
8.3 Recombinant Trypsin Solution Market Challenges
8.4 Recombinant Trypsin Solution Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novozymes
BBI Group
Roche
Thermo Fisher
Merck
Applied Biotechnology Institute
Biological Industries
Yaxin Bio
Yocon Hengye Bio
BasalMedia
Biosera

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂